Could your genes predict your arthritis Drug's success?

NCT ID NCT07388407

Recruiting now Knowledge-focused Sponsor: Foundation University Islamabad Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how a person's genes might influence how well they respond to the rheumatoid arthritis drug leflunomide and whether they experience side effects. Researchers will follow 110 Pakistani patients taking the drug for six months, tracking their symptoms and side effects while analyzing their DNA. The goal is to find genetic markers that could help doctors predict which patients will benefit most from this treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEMATOID ARTHRITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fauji Foundation Hospital, Rawalpindi
RECRUITING

Rawalpindi, Punjab Province, 46000, Pakistan

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Shifa International Hospital
COMPLETED

Islamabad, Punjab Province, 44000, Pakistan

Conditions

Explore the condition pages connected to this study.

RHEMATOID ARTHRITIS